Background. Workers in the pharmaceutical industry may be exposed to m
any potential carcinogens. We investigated cancer morbidity in a Danis
h plant where enzymes, insulin, antibiotics and sex hormones were prod
uced in substantial quantities. Methods. Altogether 10889 people ever
employed (1964-1988) at the pharmaceutical plant were retrieved from t
he files of a compulsory pension fund, and followed-up in the nationwi
de Danish Cancer Registry (1964-1989). Site-specific standardized inci
dence ratios (SIR) were estimated, based on cancer rates for the natio
nal population. information on risk factors for breast cancer, e.g. nu
mber of children, age at menarche and first delivery, obesity, and non
-occupational use of sex hormones was obtained from samples of the fem
ale employees, and compared to equivalent variables from the general p
opulation. Results. The overall SIR for women was significantly elevat
ed (n = 5554; SIR = 1.2). Excess risk was particularly seen for breast
cancer (n = 97; SIR = 1.5), especially in a subgroup who had started
work at the factory aged 30-39 and had continued to work for 1-9 years
(SIR = 2.8). The SIR was near unity for men (n = 5335); however, thre
e men with breast cancer versus 0.4 expected were found. Lifestyle com
ponents explained only about one-quarter of the excess female breast c
ancers. Proxy measures of intensity of occupational exposure to sex ho
rmones or insulin showed no association with the risk for breast cance
r. Conclusions. It seems unlikely that either a single occupational fa
ctor or an unusual reproductive pattern can explain the elevated breas
t cancer risk. Therefore, the finding requires further study.